- Available history
- No dated observations
- Data captured
IPO Date coverage
Neumora Therapeutics, Inc. (NMRA). What the retained company guidance contains and how many periods can be scored.
- Legal name: Value Neumora Therapeutics, Inc..
- Ticker: Value NMRA.
- Exchange: Value Nasdaq.
- IPO date: Value 18 Sep 2023.
| Measure | Value |
|---|---|
| Legal name | Neumora Therapeutics, Inc. |
| Ticker | NMRA |
| Exchange | Nasdaq |
| IPO date | 18 Sep 2023 |
| Country of operation (business address) | United States |
| Final IPO prospectus | Form 424B4 filed 2023-09-18, accession 0001193125-23-236920 |
| Registration statement | Form S-1 filed 2023-08-25, accession 0001193125-23-221589 |
| Current registered country | Delaware, United States SEC EDGAR state of incorporation DE |
| Business address | 260 ARSENAL PLACE, SUITE 1, WATERTOWN, Massachusetts, 02472, United States |
| Mailing address | 260 ARSENAL PLACE, SUITE 1, WATERTOWN, Massachusetts, 02472, United States |
| Industry (SIC) | 2836 Biological Products, (No Diagnostic Substances) |
| Fiscal year end | 12-31 |
| Filer category | Non-accelerated filer<br>Smaller reporting company |
| Listed stock (Section 12(b)) | Common stock, par value $0.0001 per share · NMRA · Nasdaq Global Select Market 10-Q filed 2026-08-14 cover |
| Shell company | No 10-Q filed 2026-08-14 cover |
| Smaller reporting company | Yes 10-Q filed 2026-08-14 cover |
| Emerging growth company | No 10-Q filed 2026-08-14 cover |
| Current in its reporting | Yes 10-Q filed 2026-08-14 cover |
| Well-known seasoned issuer | No 10-K filed 2026-03-30 cover |
| Voluntary filer | No 10-K filed 2026-03-30 cover |
| First EDGAR filing | 2021-11-08 (DRS) |
| SEC CIK | 1885522 |
| EIN | 844367680 |
| Phone | (857) 760-0900 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |